The Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information Technology announced the selection of nine pilots as part of the Behavioral Health Information ...
When Rob Purinton became chief AI officer at Altamonte Springs, Fla.-based AdventHealth in January 2025, he assumed first-year success would be defined by establishing governance and credibility.
Harbor SMID Cap Core ETF returned 1.13% in Q4, trailing the Russell 2500 Index. View the full performance and sector ...
While a rating can be helpful, a nutritionist raises a concern that the proposed system may foster a mindset in which food is seen as either 'good' or 'bad,' overlooking the many ways it can fit into ...
Google recently decided to remove inaccurate AI-generated health summaries from its search results. While OpenAI launched ChatGPT Health gving users access to health and wellness information, its ...
WPBF Channel 25 on MSN
Florida AG James Uthmeier launches China unit targeting scams, data abuse
Florida AG James Uthmeier announces new “China Prevention Unit” to investigate consumer scams, data privacy violations and alleged deceptive practices tied to foreign entities.
VSee Health (NASDAQ:VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. The Company's offerings integrate ...
TravelPulse on MSN
AmaWaterways Strengthens Leadership Team With New Appointments
AmaWaterways has strengthened its leadership team by appointing Virginia Suliman as Chief Technology Officer and Michael ...
ZACK Polanski has demanded that the UK Government scraps its contracts with Palantir, amid mounting questions over Peter ...
Taiwanese doctors warned against using artificial intelligence (AI) for health advice, after a German study showed that Google AI cited YouTube videos in answers about medicine read by billions of ...
The primary finding from the clinical trials for the COPD biologics is reduced annual exacerbations by 30% (BOREAS trial) and 34% (NOTUS trial). In the BOREAS trial, in addition to reduced ...
BNY Mellon Dynamic Value Fund (Class A at NAV) returned 4.84% during the fourth quarter of 2025. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results